Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.07% vs 7.92% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -42.51% vs 84.77% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -35.21% vs 63.02% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 19.29% vs 8.74% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Rohto Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.07% vs 7.92% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 9.58% vs 18.73% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -42.51% vs 84.77% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.26% vs 24.59% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -35.21% vs 63.02% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 11.62% vs 51.73% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 19.29% vs 8.74% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -3.64% vs 2,306.25% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






